Global22 May 2026 at 11:24 am
Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT

Global
Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT
Article Details
Category: Global
Published: 22 May 2026
Time: 11:24 am
Author: Muhammad Sheikh
More Stories



